Towards optimization of ceftazidime dosing in obese ICU patients: the end of the ‘one-size-fits-all’ approach?

The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key

(2022) Pierre Delanaye et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Ceftazidime dosing in obese patients: is it time for more?

(2022) Cornélie Fanton D’Andon et al.   Expert Opinion on Drug Metabolism & Toxicology

Ceftazidime Concentration is Correlated to the Glomerular Filtration Rate and Body Mass Index

(2022) Manon Launay et al.   THERAPEUTIC DRUG MONITORING

Nosocomial Infection

(2021) Marin H. Kollef et al.   CRITICAL CARE MEDICINE

Global pandemics interconnected — obesity, impaired metabolic health and COVID-19

(2021) Norbert Stefan et al.   Nature Reviews Endocrinology

Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance

(2021) Magalie Collet et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients

(2021) David Busse et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

(2020) Mohd H. Abdul-Aziz et al.   INTENSIVE CARE MEDICINE

Obesity in the critically ill: a narrative review

(2019) Miet Schetz et al.   INTENSIVE CARE MEDICINE

Obesity, kidney dysfunction and hypertension: mechanistic links

(2019) John E. Hall et al.   Nature Reviews Nephrology

Medical Versus Surgical ICU Obese Patient Outcome

(2018) Audrey De Jong et al.   CRITICAL CARE MEDICINE

Being Overweight Is Associated With Greater Survival in ICU Patients

(2015) Yasser Sakr et al.   CRITICAL CARE MEDICINE

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Broad-spectrum β-lactams in obese non-critically ill patients

(2014) M Hites et al.   Nutrition & Diabetes

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Case-Control Study of Drug Monitoring of  -Lactams in Obese Critically Ill Patients

(2012) M. Hites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

(2012) Fekade Sime et al.   Annals of Intensive Care

Therapeutic drug monitoring of antimicrobials

(2011) Jason A. Roberts et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

(2010) Marta Ulldemolins et al.   CLINICAL PHARMACOKINETICS

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION